Market overview
The global nasal congestion treatment devices market is worth USD 735 mn in 2026 and is forecast to reach USD 1.2 bn by 2036, growing at a 4.8% CAGR. United States is the largest country market and Saline irrigation systems is the largest by product segment.
| Scope | Non-drug devices for blocked noses: nasal strips and dilators, electronic and powered nasal irrigators, saline rinse bottles and nasal inhalers sold to consumers. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 700 mn |
| Value 2026 | USD 735 mn |
| Value 2036 | USD 1.2 bn |
| CAGR 2026-2036 | 4.8% |
| Volume 2026 | 57.2 million units |
| Volume 2036 | 82.7 million units |
| Average price 2026 | USD 12.8 per unit |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Nasal Congestion Treatment Devices market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 735.0 mn |
| 2027 | USD 770.3 mn |
| 2028 | USD 807.3 mn |
| 2029 | USD 846.0 mn |
| 2030 | USD 886.6 mn |
| 2031 | USD 929.2 mn |
| 2032 | USD 973.8 mn |
| 2033 | USD 1.02 bn |
| 2034 | USD 1.07 bn |
| 2035 | USD 1.12 bn |
| 2036 | USD 1.17 bn |
Nasal Congestion Treatment Devices market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Nasal strips and dilators | 34.0% | 30.9% | USD 250 mn | 3.8% |
| Saline irrigation systems | 38.0% | 38.0% | USD 279 mn | 4.8% |
| Powered nasal irrigators | 12.0% | 15.9% | USD 88 mn | 7.8% |
| Other devices | 16.0% | 15.2% | USD 118 mn | 4.3% |
By channel
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Pharmacies and drugstores | 48.0% | 42.2% | USD 353 mn | 3.5% |
| Online | 26.0% | 35.6% | USD 191 mn | 8.1% |
| Supermarkets and mass retail | 26.0% | 22.2% | USD 191 mn | 3.2% |
By mechanism
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Nasal strips and dilators | 26.0% | 24.0% | USD 191 mn | 4.0% |
| Saline irrigation devices | 30.0% | 29.0% | USD 220 mn | 4.5% |
| Nasal aspirators and suction | 14.0% | 14.0% | USD 103 mn | 4.8% |
| Humidifiers and steam inhalers | 18.0% | 17.0% | USD 132 mn | 4.2% |
| Electronic and neuromodulation devices | 12.0% | 16.0% | USD 88 mn | 7.9% |
By user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Adults | 62.0% | 60.0% | USD 456 mn | 4.5% |
| Children and infants | 24.0% | 24.0% | USD 176 mn | 4.8% |
| Athletes and sleepers | 14.0% | 16.0% | USD 103 mn | 6.2% |
By price tier
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Value | 36.0% | 32.0% | USD 265 mn | 3.6% |
| Mid-range | 42.0% | 43.0% | USD 309 mn | 5.0% |
| Premium | 22.0% | 25.0% | USD 162 mn | 6.2% |
Top 25 countries for nasal congestion treatment devices by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 83.0% of 2026 revenue and the 25 countries below together hold 95.2%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 265 mn | 36.0% | USD 404 mn | 4.3% |
| 2 | China | USD 74 mn | 10.0% | USD 149 mn | 7.3% |
| 3 | Japan | USD 59 mn | 8.0% | USD 86 mn | 3.8% |
| 4 | Germany | USD 44 mn | 6.0% | USD 65 mn | 3.9% |
| 5 | United Kingdom | USD 37 mn | 5.0% | USD 54 mn | 3.9% |
| 6 | France | USD 33 mn | 4.5% | USD 48 mn | 3.8% |
| 7 | India | USD 29 mn | 4.0% | USD 62 mn | 7.8% |
| 8 | Canada | USD 26 mn | 3.5% | USD 39 mn | 4.2% |
| 9 | Brazil | USD 22 mn | 3.0% | USD 38 mn | 5.5% |
| 10 | Australia | USD 22 mn | 3.0% | USD 34 mn | 4.5% |
| 11 | Italy | USD 14 mn | 1.8% | USD 21 mn | 4.6% |
| 12 | Spain | USD 12 mn | 1.7% | USD 19 mn | 4.6% |
| 13 | Netherlands | USD 11 mn | 1.4% | USD 17 mn | 4.6% |
| 14 | South Korea | USD 8.6 mn | 1.2% | USD 14 mn | 4.6% |
| 15 | Mexico | USD 7.2 mn | 1.0% | USD 11 mn | 4.6% |
| 16 | Russia | USD 6.2 mn | 0.8% | USD 9.9 mn | 4.7% |
| 17 | Turkey | USD 5.4 mn | 0.7% | USD 8.6 mn | 4.7% |
| 18 | Poland | USD 4.7 mn | 0.6% | USD 7.4 mn | 4.6% |
| 19 | Sweden | USD 4.4 mn | 0.6% | USD 6.9 mn | 4.6% |
| 20 | Switzerland | USD 3.8 mn | 0.5% | USD 5.9 mn | 4.6% |
| 21 | Indonesia | USD 3.4 mn | 0.5% | USD 5.3 mn | 4.6% |
| 22 | Taiwan | USD 3.0 mn | 0.4% | USD 4.8 mn | 4.8% |
| 23 | Thailand | USD 2.6 mn | 0.3% | USD 4.0 mn | 4.5% |
| 24 | Belgium | USD 2.3 mn | 0.3% | USD 3.6 mn | 4.8% |
| 25 | Saudi Arabia | USD 2.0 mn | 0.3% | USD 3.2 mn | 4.8% |
| Rest of world | USD 35 mn | 4.8% | USD 55 mn | 4.6% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Haleon
- Procter & Gamble
- Church and Dwight
Group 2: Regional and specialist players
- NeilMed Pharmaceuticals
- Navage
- Nozovent
- Laboratoires Gilbert
Group 3: Emerging and niche players
- Rhinomed
- Alkalol
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the nasal congestion treatment devices market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 4.8% is calculated from the resulting values.
The market is divided by product, by channel, by mechanism, by user, by price tier. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the nasal congestion treatment devices market?
The global nasal congestion treatment devices market is estimated at USD 700 mn in 2025 and USD 735 mn in 2026.
How fast will the nasal congestion treatment devices market grow?
It is forecast to reach USD 1.2 bn by 2036, a compound annual growth rate of 4.8% from 2026, an increase of USD 440 mn.
Which country is the largest market for nasal congestion treatment devices?
United States is the largest market by revenue at USD 265 mn in 2026, 36.0% of the global total. The three largest countries together hold 54.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 7.8% a year from 2026 to 2036.
Which nasal congestion treatment devices segment is largest?
In the by product split, Saline irrigation systems is the largest segment with 38.0% of 2026 revenue.
Who are the leading nasal congestion treatment devices companies?
Global leaders include Haleon, Procter & Gamble, Church and Dwight.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Extracorporeal Membrane OxygenationUSD 738 mn · 5.5% CAGR
- Fluid Bed DryerUSD 742 mn · 6.0% CAGR
- 1-Step RT-PCR KitsUSD 728 mn · 5.0% CAGR
- Cervical Spacer SystemsUSD 746 mn · 6.0% CAGR
- Patient-Specific Surgical Implant DesignUSD 722 mn · 10.5% CAGR
- Smart InhalerUSD 713 mn · 15.0% CAGR
- AI-Powered Behavioral TherapyUSD 768 mn · 17.0% CAGR
- Precision Transplant MedicineUSD 770 mn · 9.5% CAGR